Ignite Creation Date:
2025-12-24 @ 2:49 PM
Ignite Modification Date:
2026-02-02 @ 10:42 AM
Study NCT ID:
NCT04520659
Status:
COMPLETED
Last Update Posted:
2025-08-22
First Post:
2020-08-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, LID/ΔM2-2/1030s, in RSV-Seronegative Infants and Children 6 to 24 Months of Age
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | RSV Infection | View |
Keywords: